Trial Outcomes & Findings for Usability Testing of Affordable Haptic Robots for Stroke Therapy (NCT NCT02772809)

NCT ID: NCT02772809

Last Updated: 2020-09-04

Results Overview

The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

At 0 weeks

Results posted on

2020-09-04

Participant Flow

Stroke survivors over the age of 18 with hemiplegia, who are three months post event, and have varying levels of impairment in the upper extremities will be recruited. All use of the TheraDrive system will take place at the Rehabilitation Robotics Lab on the first floor of Penn Rittenhouse

Participant milestones

Participant milestones
Measure
Stroke Survivors With Varying Levels of Motor Impairment
Stroke survivors with varying levels of motor deficit impairment in their upper extremity.
Overall Study
STARTED
23
Overall Study
COMPLETED
17
Overall Study
NOT COMPLETED
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Stroke Survivors With Varying Levels of Motor Impairment
Stroke survivors with varying levels of motor deficit impairment in their upper extremity.
Overall Study
not completed some tasks
6

Baseline Characteristics

6 persons did not complete all of the tracking tasks so the data was excluded.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Subjects With Varying Levels of Motor Impairment
n=23 Participants
Subjects with varying levels of motor impairments who are ages 18 and older.
Age, Categorical
<=18 years
0 Participants
n=23 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
n=23 Participants
Age, Categorical
>=65 years
0 Participants
n=23 Participants
Sex: Female, Male
Female
9 Participants
n=17 Participants • 6 persons did not complete all of the tracking tasks so the data was excluded.
Sex: Female, Male
Male
8 Participants
n=17 Participants • 6 persons did not complete all of the tracking tasks so the data was excluded.

PRIMARY outcome

Timeframe: At 0 weeks

Population: 6 subjects did not complete so not included in the analysis

The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Fugl Meyer
42.5 score on a scale
Standard Deviation 20.2

PRIMARY outcome

Timeframe: At Session 0. Pre-intervention

Population: 6 subjects did not complete so not included in the analysis

Measures ADL Function. Completed reach and grasp activities. Reached for 1 inch cube and placed with impaired arm. More blocks indicate higher function. Less blocks lower function

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Box and Blocks
19.11 # of blocks
Standard Deviation 15.49

PRIMARY outcome

Timeframe: At Session 0

Population: 6 subjects did not complete so not included in the analysis

Tracking accuracy is measured using the normalized root mean square, which is a measure for error in tracking performance with respect to a desired goal. Root mean squared divided by the maximum error if person does not move. The higher the decimal the higher the error made. Lower is better performance.

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Tracking Accuracy
0.73 accuracy index
Standard Deviation 0.44

SECONDARY outcome

Timeframe: pre-intervention

Population: 6 subjects did not complete so not included in the analysis

Grip strength as measured by a dynamometer. Subjects were asked to squeeze a dynamometer with impaired arm. Higher forces mean better function

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Grip Strength
26.88 lbs
Standard Deviation 22.73

SECONDARY outcome

Timeframe: pre-intervention

Population: 6 subjects did not complete so not included in the analysis

A brief 30-question test that takes around 10 to 12 minutes to complete and helps assess people for impairment in cognition domains. Maximum is 30. Minimum is 0; Low is \<17 is severe cognitive impairment; a score 26 and higher is normal cognition.

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Montreal Cognitive Assessment (MOCA)
22.5 units on a scale
Standard Deviation 4.6

SECONDARY outcome

Timeframe: Pre-intervention

Population: 6 subjects did not complete so not included in the analysis

Measures depression. The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1961). Maximum is 63 Total Score\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Levels of Depression 1-10\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_These ups and downs are considered normal 11-16\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Mild mood disturbance 17-20\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Borderline clinical depression 21-30\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Moderate depression 31-40\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Severe depression over 40\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Extreme depression

Outcome measures

Outcome measures
Measure
Stroke Survivors With Motor Impairment
n=17 Participants
All subject used robot for tracking tasks
Becks Depression Scale
7.25 units on a scale
Standard Deviation 5.72

Adverse Events

Haptic Robot Therapy With Games

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Michelle J Johnson

University of Pennsylvania

Phone: 215 893-2665

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place